These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11979840)

  • 1. [Maintenance treatment after success of H. pylori eradication].
    Aoyama N; Shirasaka D; Miki I
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():523-30. PubMed ID: 11979840
    [No Abstract]   [Full Text] [Related]  

  • 2. Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: prospective randomized controlled trial.
    Murakami K; Sato R; Okimoto T; Watanabe K; Nasu M; Kodama M; Fujioka T
    J Gastroenterol Hepatol; 2006 Jun; 21(6):1048-53. PubMed ID: 16724993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
    Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer.
    Gisbert JP; Khorrami S; Carballo F; Calvet X; Gene E; Dominguez-Muñoz E
    Aliment Pharmacol Ther; 2004 Mar; 19(6):617-29. PubMed ID: 15023164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Audit of the change of outcome of peptic ulcer disease following treatment of Helicobacter pylori.
    Jost C; Marbet UA
    Schweiz Med Wochenschr; 1998 Jan; 128(3):64-71. PubMed ID: 9498257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Helicobacter pylori infections.
    Thijs JC; Kuipers EJ; van Zwet AA; Pena AS; de Graaff J
    QJM; 1995 Jun; 88(6):369-89. PubMed ID: 7648229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptic ulcer disease: paradigms lost.
    Sarner A; Babyatsky MW
    Mt Sinai J Med; 1996; 63(5-6):387-98. PubMed ID: 8898545
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of maintenance therapy by H2RA on the recurrence of gastric and duodenal ulcer and on the occurrence of reflux esophagitis, gastric erosions, and duodenal erosions after H. pylori eradication].
    Maeyama S; Yoshihara H; Kamada T; Kubota S; Kobayashi I; Tsuji S; Kawano S
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():512-5. PubMed ID: 16363591
    [No Abstract]   [Full Text] [Related]  

  • 9. Is maintenance acid suppression necessary to reduce the rate of reinfection with Helicobacter pylori?
    Alzoubi K; Rashdan A; Al-Dayyat A; Al-Safi S
    Hepatogastroenterology; 2007 Dec; 54(80):2406-9. PubMed ID: 18265676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
    Holtmann G; Layer P; Goebell H
    Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The analysis of the recurrence ulcer after H. pylori eradication].
    Kamada T; Chayama K; Haruma K; Yoshihara M; Ito M; Kitadai Y; Kawamura Y
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():501-5. PubMed ID: 11979837
    [No Abstract]   [Full Text] [Related]  

  • 12. Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy.
    Lanas A; Remacha B; Sáinz R; Hirschowitz BI
    Am J Gastroenterol; 2000 Feb; 95(2):513-9. PubMed ID: 10685760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H2-receptor antagonists an Helicobacter pylori eradication.
    Lamers CB
    Scand J Gastroenterol Suppl; 1995; 212():126-7. PubMed ID: 8578225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users].
    Shimada T; Yamagata M; Hiraishi H
    Nihon Rinsho; 2007 Oct; 65(10):1824-9. PubMed ID: 17926531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The significance of H. pylori eradication in NSAIDs ulcer].
    Kato M; Ono S; Mabe K; Shimizu Y; Asaka M
    Nihon Rinsho; 2011 Jun; 69(6):1049-56. PubMed ID: 21688626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of Helicobacter pylori eradication therapy on the healing process of peptic ulcers].
    Imaizumi H; Koizumi W; Nakai H; Tanabe S; Ohida M; Saigenji K
    Nihon Rinsho; 1999 Jan; 57(1):167-72. PubMed ID: 10036957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost-effectiveness of competing strategies for the prevention of recurrent peptic ulcer hemorrhage.
    Ofman J; Wallace J; Badamgarav E; Chiou CF; Henning J; Laine L
    Am J Gastroenterol; 2002 Aug; 97(8):1941-50. PubMed ID: 12190158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-week versus two-week H2-receptor antagonist in combination with amoxicillin and tinidazole for eradication of Helicobacter pylori infection.
    Hsu CC; Chen JJ; Hu TH; Lu SN; Changchien CS
    Hepatogastroenterology; 2005; 52(65):1617-21. PubMed ID: 16201128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptic ulcer recurrence after Helicobacter pylori eradication: a 5-year follow-up study.
    Fujioka T; Uribe RU; Kubota T; Murakami K; Kawasaki H; Nasu M
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S35-8. PubMed ID: 8574733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Eradication of Helicobacter pylori and use of antisecretory drugs--a population based study].
    Lassen AT; Hallas J; Schaffalitzky de Muckadell OB
    Ugeskr Laeger; 2004 Sep; 166(39):3405-7. PubMed ID: 15515395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.